Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.

Elf, S, Abdelfattah, NS, Chen, E et al. (13 more authors) (2016) Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation. Cancer discovery, 6 (4). pp. 368-381. ISSN 2159-8274

Abstract

Metadata

Authors/Creators:
  • Elf, S
  • Abdelfattah, NS
  • Chen, E
  • Perales-Patón, J
  • Rosen, EA
  • Ko, A
  • Peisker, F
  • Florescu, N
  • Giannini, S
  • Wolach, O
  • Morgan, EA
  • Tothova, Z
  • Losman, JA
  • Schneider, RK
  • Al-Shahrour, F
  • Mullally, A
Copyright, Publisher and Additional Information: © 2016, American Association for Cancer Research. This is an author produced version of a paper published in Cancer discovery. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 1 April 2016
  • Accepted: 11 February 2016
  • Published (online): 7 March 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 May 2016 11:38
Last Modified: 14 Apr 2017 04:41
Published Version: http://dx.doi.org/%2010.1158/2159-8290.CD-15-1434
Status: Published
Publisher: American Association for Cancer Research
Identification Number: https://doi.org/10.1158/2159-8290.CD-15-1434

Share / Export

Statistics